BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1681 related articles for article (PubMed ID: 25038867)

  • 1. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine's effectiveness in unipolar versus bipolar depression.
    Fond G; Boyer L
    Psychopharmacology (Berl); 2014 Nov; 231(22):4417-8. PubMed ID: 25315362
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression.
    Zhang M; Rosenheck R; Lin X; Li Q; Zhou Y; Xiao Y; Huang X; Fan N; He H
    J Affect Disord; 2018 Feb; 227():372-378. PubMed ID: 29149755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial.
    Carspecken CW; Borisovskaya A; Lan ST; Heller K; Buchholz J; Ruskin D; Rozet I
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):305-313. PubMed ID: 29847468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.
    Rhee TG; Shim SR; Forester BP; Nierenberg AA; McIntyre RS; Papakostas GI; Krystal JH; Sanacora G; Wilkinson ST
    JAMA Psychiatry; 2022 Dec; 79(12):1162-1172. PubMed ID: 36260324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials.
    Zheng W; Li XH; Zhu XM; Cai DB; Yang XH; Ungvari GS; Ng CH; Ning YP; Hu YD; He SH; Wang G; Xiang YT
    J Affect Disord; 2019 May; 250():123-131. PubMed ID: 30852364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
    Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA
    Neural Plast; 2015; 2015():858251. PubMed ID: 26137324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Low-Dose Ketamine on the Antidepressant Efficacy and Suicidal Ideations in Patients Undergoing Electroconvulsive Therapy.
    Chen Q; Dong J; Luo J; Ren L; Min S; Hao X; Luo Q; Chen J; Li X
    J ECT; 2020 Mar; 36(1):25-30. PubMed ID: 31913927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.
    Bobo WV; Vande Voort JL; Croarkin PE; Leung JG; Tye SJ; Frye MA
    Depress Anxiety; 2016 Aug; 33(8):698-710. PubMed ID: 27062450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of ketamine in electroconvulsive therapy.
    Kucia K; Merk W
    Psychiatr Pol; 2015; 49(6):1255-63. PubMed ID: 26909400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
    Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH
    Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comment on Fond and colleagues' systematic review and meta-analysis of ketamine in the treatment of depressive disorders (Psychopharmacology 2014; Jul 20 [Epub ahead of print]).
    McGirr A; Berlim MT
    Psychopharmacology (Berl); 2014 Oct; 231(19):3907-8. PubMed ID: 25176174
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.
    Abdallah CG; Fasula M; Kelmendi B; Sanacora G; Ostroff R
    J ECT; 2012 Sep; 28(3):157-61. PubMed ID: 22847373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
    Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine and electroconvulsive therapy: so happy together?
    Cobb K; Nanda M
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):459-462. PubMed ID: 29794567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
    Anand A; Mathew SJ; Sanacora G; Murrough JW; Goes FS; Altinay M; Aloysi AS; Asghar-Ali AA; Barnett BS; Chang LC; Collins KA; Costi S; Iqbal S; Jha MK; Krishnan K; Malone DA; Nikayin S; Nissen SE; Ostroff RB; Reti IM; Wilkinson ST; Wolski K; Hu B
    N Engl J Med; 2023 Jun; 388(25):2315-2325. PubMed ID: 37224232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
    Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
    J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.
    Niciu MJ; Shovestul BJ; Jaso BA; Farmer C; Luckenbaugh DA; Brutsche NE; Park LT; Ballard ED; Zarate CA
    J Affect Disord; 2018 May; 232():310-315. PubMed ID: 29501990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.